Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00254670 · ClinicalTrials.gov registry record · NA
Naltrexone Effects on Alcohol Intake
A NA study of Social Drinker, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 1
- Study location
NCT00254670 is a NA study of Social Drinker that has completed, run by University of California, San Francisco. The trial reports 1 study location across 1 state.
The verdict
NCT00254670, a NA study of Social Drinker, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 1
- Study location
Study Summary
The purpose of this study is to examine drinking behavior and decision-making while taking Naltrexone and placebo. This is a double-blind, randomized, placebo-controlled crossover study. There are two cycles: one cycle on Naltrexone and one cycle on placebo.
Conditions Studied
Interventions
- DRUG Naltrexone
Study Locations (1)
California
- UCSF - San Francisco
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-02 |
| Est. Completion | 2006-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00254670
The ClinicalTrials.gov registry entry for NCT00254670 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Social Drinker appearing as the primary indexed condition, and to 1 intervention - of which Naltrexone is the first listed.
NCT00254670 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00254670 about?
NCT00254670 is a clinical study titled "Naltrexone Effects on Alcohol Intake". The purpose of this study is to examine drinking behavior and decision-making while taking Naltrexone and placebo. This is a double-blind, randomized, placebo-controlled crossover study. There are two cycles: one cycle on Naltrexone and one cycle on placebo.
What is the current status of trial NCT00254670?
This trial is currently completed. It is a NA study. The study started on 2005-02. Estimated completion is 2006-12.
What conditions does trial NCT00254670 study?
This clinical trial studies the following conditions: Social Drinker.
What interventions are being tested in trial NCT00254670?
The interventions under investigation include: Naltrexone (DRUG).
Who is sponsoring clinical trial NCT00254670?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00254670 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.